These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1421451)

  • 1. Computed tomography in the identification of gallstones likely to respond to UDCA.
    Caroli A; Di Mario F; Spigariol F; Meggiato T; Scalon P; Basso D; Del Favero G
    Ital J Gastroenterol; 1992 Oct; 24(8):466-7. PubMed ID: 1421451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Computed X-ray tomography in predicting the efficacy of oral cholelithiasis with bile acids].
    Fu XB
    Zhonghua Yi Xue Za Zhi; 1993 Feb; 73(2):81-4, 126. PubMed ID: 8391902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography in predicting the efficacy of oral cholelitholysis with bile acids.
    Fu XB; Liu JY; Liu GN; Shao XM; Zhou XS
    Chin Med J (Engl); 1993 Oct; 106(10):734-8. PubMed ID: 8033604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical dissolution of gallstones by ursodeoxycholic acid: a clinical trial on 14 patients.
    Lin JT; Wang JT; Wang TH; Su CT
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):370-6. PubMed ID: 2794937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter study on the litholytic effect of ursodeoxycholic acid. 30 cases].
    Voirol M; Stalder GA; Fasel J; Séchaud R; Desbaillets LG; Kapp F; Krieg P; Aenishänslin HW; Wyss G
    Schweiz Med Wochenschr; 1983 Apr; 113(17):643-5. PubMed ID: 6346484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
    Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
    Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
    Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
    Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is computed tomography a reliable indicator of stone solubility?
    Caroli A; Del Favero G; Di Mario F; Spigariol F; Naccarato R
    Ital J Gastroenterol; 1990 Apr; 22(2):82. PubMed ID: 2131937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography in predicting gall stone solubility: a prospective trial.
    Caroli A; Del Favero G; Di Mario F; Spigariol F; Scalon P; Meggiato T; Zambelli C; Naccarato R
    Gut; 1992 May; 33(5):698-700. PubMed ID: 1612490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli's syndrome.
    Ros E; Navarro S; Bru C; Gilabert R; Bianchi L; Bruguera M
    Lancet; 1993 Aug; 342(8868):404-6. PubMed ID: 8101905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.
    Gleeson D; Ruppin DC; Saunders A; Murphy GM; Dowling RH
    Q J Med; 1990 Jul; 76(279):711-29. PubMed ID: 2217675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early results of combined electrohydraulic shock-wave lithotripsy and oral litholytic therapy of gallbladder stones at the University of Iowa.
    Maher JW; Summers RW; Dean TR; Swift J; Heitshusen D; Quinn G
    Surgery; 1990 Oct; 108(4):648-52; discussion 653-4. PubMed ID: 2218875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Innovations in the diagnosis and treatment of cholelithiasis].
    Ivanchenkova RA; Egorov AV; Leonovich AE; At'kova ER
    Eksp Klin Gastroenterol; 2012; (4):66-73. PubMed ID: 23402157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of ursodeoxycholic acid in persistent gallbladder lithiasis and persistent biliary sludge: preliminary results of a multicenter experience].
    Guma C; Viola L; Apestegui C; Pinchuk L; Groppa J; Michelini J; Martínez B; Bolaños R; Toselli L
    Acta Gastroenterol Latinoam; 1994; 24(4):233-7. PubMed ID: 7701907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal shock wave lithotripsy of gallstones: results and 6-month follow-up in 141 patients.
    Torres WE; Steinberg HV; Davis RC; Baumgartner BR; Nelson RC; Casarella WJ
    Radiology; 1991 Feb; 178(2):509-12. PubMed ID: 1987616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
    Miettinen TE; Tarpila S; Gylling H
    Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
    Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.